Special statement: This article is intended only for internal industry research and exchange, and does not make any brand or product recommendations. Access is prohibited for minors.
Pharmo International's subsidiary in South Korea recently announced that to celebrate the sixth anniversary of their heat-not-burn product, IQOS, the prices of IQOS Illuma and IQOS Illuma One will be reduced by 20,000 Korean won for three weeks starting on May 4th.
During the promotional period, IQOS Illuma and IQOS Illuma One will be sold at discounted prices of 79,000 won and 49,000 won respectively, which is a discount of 20,000 won from their original prices.
The promotional event will take place in most IQOS stores in South Korea, as well as official distributors and convenience stores. Consumers can also participate in the promotion on the IQOS official online store.
It is worth noting that this promotion cannot be combined with other discount activities, such as trade-in programs and referral discount plans.
Reference:
Korea Philip Morris to Launch Special Promotion for 'il-luma' and 'won' in Commemoration of 6th Anniversary of IQOS Release.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
